IBIO: Rega marang dodolan iBio Inc
iBio, Inc. utilizes AI to develop antibodies, fully outsourcing production and testing to third-party contractors. The historical P/S trend visualizes market expectations, where 45.10 indicates the value of this parameter. Currently, iBio, Inc. has no recurring revenue, relying instead on the success of its developments. Meanwhile, deep integration with global partners optimizes research costs and minimizes operational risks.
Rincian metrik lan analitis perusahaan iBio Corp (IBIO)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal iBio, Inc.|IBIO - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal iBio Corporation|IBIO - Gunggung utang perusahaan|Rasio utang marang aset resik iBio Corp|IBIO - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak iBio|Rasio likuiditas darurat ibioinc.com
- data bathi resik lan rasio valuasi:
IBIO - Bathi resik|Bathi mangsa ngarep iBio, Inc.|IBIO - Koefisien rega marang bathi|Kapitalisasi marang proyeksi bathi iBio Inc|IBIO - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan iBio Corp|IBIO - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan iBio|IBIO - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan ibioinc.com|IBIO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep iBio, Inc.
- rincian pendapatan lan dodolan emiten:
Ringkesan analitik perusahaan:ibioinc.com, IBIO
The P/S ratio compares the market capitalization of iBio, Inc. (IBIO) to its generated revenue, determining the cost of each dollar of sales. For a biotech firm facing liquidity shortages and costly AI development, this metric reflects the extent to which investor expectations are inflated relative to actual cash flows. By analyzing the historical P/S values of iBio, Inc. (IBIO), one can identify points of extreme overvaluation or undervaluation of the asset. Long-term consensus requires benchmarking this metric against the rate of capital dilution.
Perusahaan pesaing
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA Bio - Multiplikator P/S|Koefisien rega marang pendapatan Protagonist Corp PTGX|IMVT: Multiplikator P/S|KNSA (kiniksa.com) - Rasio rega marang pendapatan|GRFS (Grifols) - Multiplikator P/S|Adaptive Biotech (ADPT) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Celldex (CLDX)|AUPH - Rega marang dodolan|BioCryst - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan VERA|Dianthus Therapeutics, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan Pharvaris NV PHVS|AbCellera Biologics Inc (ABCL) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan TRML|PGEN (Precigen, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan pharming.com (PHAR)|Kapitalisasi marang pendapatan NKTR (Nektar Therapeutics Inc.)|Koefisien rega marang pendapatan Upstream Bio, Inc.|Multiplikator P/S ZBIO (Zenas Biopharma, Inc.)|Koefisien rega marang pendapatan Immunome Bio (IMNM)|Gossamer Bio, Inc. - Multiplikator P/S|KALV: Rasio rega marang pendapatan|SEPN: Multiplikator P/S|PVLA - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Savara Corp|Rega marang dodolan Rigel Corp RIGL|Rasio rega marang pendapatan AnaptysBio, Inc. (ANAB)|ATXS: Rasio rega marang dodolan|Multiplikator P/S ENGN (enGene)|Rasio kapitalisasi pasar marang pendapatan RAPT|Aerovate - Multiplikator P/S|ACRS - Multiplikator P/S|Kyverna Therapeutics (KYTX) - Rasio rega marang pendapatan|tizianalifesciences.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Cabaletta Bio|Kapitalisasi marang pendapatan Ventyx Biosciences Inc. (VTYX)|Multiplikator P/S THTX|Multiplikator P/S Avalo Therapeutics Inc (AVTX)|Eledon Pharmaceuticals - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan AGEN|Climb Bio - Multiplikator P/S|Koefisien rega marang pendapatan Zura Bio Ltd ZURA|aTyr (ATYR) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Adagene Inc.|Rasio rega marang pendapatan ImageneBio|Kapitalisasi marang pendapatan Shattuck Therapeutics (STTK)|Kapitalisasi marang pendapatan EQ (Equillium, Inc.)|Multiplikator P/S connectbiopharm.com (CNTB)|Rasio rega marang pendapatan Immunic IMUX|ATRA: Rasio kapitalisasi marang pendapatan|InflaRx GmbH - Multiplikator P/S|Rega marang dodolan x4pharma.com|ACET: Multiplikator P/S|CELU - Koefisien rega marang pendapatan|INMB (INmune Bio Corp) - Multiplikator P/S|Rasio rega marang pendapatan BRNS|Multiplikator P/S KZR|Koefisien rega marang pendapatan sabbiotherapeutics.com|Rasio rega marang pendapatan Akari Therapeutics Plc AKTX|Enlivex Therapeutics Ltd (ENLV) - Rega marang dodolan|QTTB: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan GOVX (GeoVax Corp)|EDSA: Multiplikator P/S|CARM - Koefisien rega marang pendapatan|Rasio rega marang pendapatan XTL Biopharmaceuticals Ltd.|Rasio kapitalisasi marang pendapatan BOLT (Bolt Bio)|Multiplikator P/S HCWB|Kapitalisasi marang pendapatan aptevotherapeutics.com APVO|AIM ImmunoTech Inc. - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Aditxt Inc. (ADTX)|GRI Bio - Multiplikator P/S|Koefisien rega marang pendapatan XORTX Therapeutics Inc XRTX|HIND: Multiplikator P/S|REVB (Revelation Biosciences Corp) - Rasio rega marang pendapatan|INDP (Indaptus Therapeutics) - Multiplikator P/S|scinai.com (SCNI) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan CalciMedica, Inc. (CALI)|AFMD - Rega marang dodolan|Rasio rega marang pendapatan Allakos ALLK|HOOK (HOOKIPA Pharma, Inc.) - Rasio rega marang dodolan|IGM Bio - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ITOS (iteostherapeutics.com)|OCEA: Multiplikator P/S|TC BioPharm (Holdings) Plc (TCBP) - Multiplikator P/S|Rasio rega marang pendapatan Third Harmonic Bio, Inc
